Emerald Advisers, LLC Ionis Pharmaceuticals Inc Transaction History

Emerald Advisers, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$25.61 - $35.1 $430,632 - $590,206	-16,815 Closed	0 $0
Q3 2021 Oct 28, 2021	SELL	$33.54 - $40.55 $27,033 - $32,683	-806 Reduced 4.57%	16,815 $564,000
Q1 2021 Apr 29, 2021	BUY	$42.51 - $63.78 $749,068 - $1.12 Million	17,621 New	17,621 $792,000
Q4 2017 Feb 05, 2018	SELL	$50.3 - $64.39 $1.11 Million - $1.43 Million	-22,132 Closed	0 $0
Q3 2017 Oct 30, 2017	BUY	$45.56 - $59.57 $1.01 Million - $1.32 Million	22,132	22,132 $1.12 Million

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Emerald Advisers, LLC with notifications on news.